MIT biologists have developed a genetically modified version of a common gut bacteria that could be used to treat disease, reports Catherine Woods for the PBS NewsHour. “You could engineer a Bacteroides to live in the gut and detect when inflammation is just starting…so that you can seek treatment right away,” explains Prof. Timothy Lu.
Researchers at MIT have developed tools that could one day allow intestinal bacteria to monitor, diagnose and treat diseases, writes Eryn Brown for The Los Angeles Times. "Just as you'd program computers, we're starting to learn how to program cells by modifying their DNA," says Prof. Timothy Lu.
CNBC reporter Meg Tirrell reports on the biotechnology boom in Cambridge, explaining that one reason so many biotech companies want to be located in Kendall Square is the area’s proximity to MIT. “Everybody wants to be next to MIT, this hotbed of technology and life sciences work,” says Tirrell.
In a piece for The Huffington Post, Zeynep Ilyaz explains how Prof. Sangeeta Bhatia serves as an inspiration to her, citing her research advances in biotech and medicine, and her mentorship of women pursuing careers in STEM fields. “Dr. Bhatia is constantly looking for the next groundbreaking discovery in health, which makes her an excellent role model for girls and women,” Ilyaz writes.
Researchers from MIT and Harvard have identified the optical features within a limpet’s shell that allow the mollusk to display blue stripes, reports Nidhi Subbaraman for BetaBoston. The findings could inspire developments in augmented reality screens.
Sarah Hedgecock writes for Forbes about how researchers have made major advances in mapping the human epigenome. Prof. Manolis Kellis explains that the new findings allow researchers to “ go from a static picture of the genome, which is effectively the book of life, to a dynamic picture of a genome.”
A team of researchers has published a map of the human epigenome, which could be useful in better understanding how to treat disease, writes Amanda Schupak for CBS News. Prof. Manolis Kellis explains that the findings provide “a reference for studying the molecular basis of human disease, by revealing the control regions that harbor genetic variants associated with different disorders."
Marcus Woo writes for Wired about how researchers have published a number of articles providing new information on the human epigenome, which controls which genes get switched on or off. “It is giving us a view of the living, breathing genome in motion, as opposed to a static picture of DNA,” explains Prof. Manolis Kellis.
Rachel Feltman of The Washington Post reports that a team led by Professor Manolis Kellis has released the most complete map of the human epigenome to date. “The researchers tied specific cell changes to 58 different biological traits,” writes Feltman. “Sometimes the epigenomic changes of a cell reveal possible clues about disease.”
Work on mapping the human epigenome, led by Professor Manolis Kellis, could reveal the origins of diseases such as cancer and Alzheimer’s, reports Carolyn Johnson for The Boston Globe. “The research was one major piece of a $240 million National Institutes of Health program that funded 88 grants over 10 years,” Johnson explains.
For the first time, researchers have mapped the epigenome, identifying the switches that can turn individual genes on or off, reports Sharon Beagley for Reuters. Says Prof. Manolis Kellis of the need to understand the epigenome, "The only way you can deliver on the promise of precision medicine is by including the epigenome.”
Researchers have mapped the epigenome, shedding light on how genes are controlled, which could be useful in understanding disease, reports Gina Kolata for The New York Times. “We now have an unprecedented view of the living human genome,” says Prof. Manolis Kellis.
Prof. Robert Langer speaks with Chris Baraniuk of New Scientist about winning the Queen Elizabeth Prize for Engineering and his career in biotechnology. “It’s going to be the entrepreneurs, the new professors, the young people who are willing to think outside the box and not necessarily go down a conventional path,” says Langer of the future of medicine.
Kevin Hartnett of The Boston Globe looks at Professor Christine Ortiz’s work to develop better body armor technology by mimicking the tough qualities of fish scales. “Armored fish have multi-hit capability,” explains Ortiz. “Basically, when it gets hit, it just cracks locally in a circle.”
Professor Robert Langer has won the Queen Elizabeth Prize for Engineering for his pioneering work with medical technologies, reports David Shukman for BBC News. Shukman notes that “as many as two billion people have in some way been touched by technologies devised and developed by him and his teams.”